Activation of the NF-κB/NLRP3 axis by USP38 accelerates adverse atrial remodeling under hemodynamic stress, suggesting USP38 as a potential therapeutic target for pressure-overload-induced AF. The gene discussed is USP38; the disease is atrial fibrillation.